Several genetic studies have reported that deletion or mutation of A20 is associated with hematologic malignancies, such as multiple lymphoma, MALT lymphoma, Hodgkin’s disease, and follicular lymphoma, which are characterized by NF-κB signal activation [23–26]. The gene discussed is NFKB1; the disease is Hodgkins lymphoma.